Physician profile
Nestor Cohenca
NPI 1831286178
$29,220.57
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,336 · 2020: $319 · 2021: $60.02 · 2022: $14K · 2023: $14K · 2024: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $88.82 · Gift: $62.49 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,650.00 |
| Food and Beverage | $88.82 |
| Gift | $62.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carestream Dental, LLC | $27,371.98 | 2019-2023 | |
| A-Dec, INC. | $691.70 | 2019-2021 | |
| Sonendo INC | $638.00 | 2019-2024 | Gentlewave G4 Console |
| Carl Zeiss Meditec Ag | $258.85 | 2020 | |
| Dentsply Sirona INC | $64.22 | 2023-2024 | Trunatomy Rotary File, Smartlite Focus |
| Ultradent Products INC | $62.49 | 2024 | Opalescence |
| Septodont INC. | $54.09 | 2024 | Bioroot Flow (Sample) |
| Henry Schein, INC. | $34.95 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Tulsa Dental Products LLC | $14.03 | 2019 | |
| Gc America INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nestor Cohenca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.